Bourses / Financement / concours de projets

Accueil > Formation > Bourses / Financement / concours de projets

Bourse MD-PhD / Bourse clinicien-chercheur – UdeM

Date limite : 1er décembre 2026

Montant

50 000 $ par année pour trois (3) ans

Objectifs

Offrir un soutien financier :

aux étudiant·e·s en médecine (1er cycle) de l’Université de Montréal qui souhaitent entreprendre un Ph.D. dans le domaine de la dermatologie ;
aux résident·e·s en dermatologie de l’Université de Montréal qui envisagent de s’inscrire au programme de clinicien-chercheur.

Description de la bourse

Une bourse de 50 000 $ par année pour trois (3) ans est octroyée grâce au don du Dr Robert Bissonnette, diplômé de la Faculté de médecine. Elle s’inscrit dans le cadre du Fonds de bourses pour la recherche en dermatologie.

Critères d'admissibilité

Être citoyen·ne canadien·ne ou résident·e permanent·e.
Être inscrit·e au doctorat de 1er cycle en médecine ou être médecin-résident·e à l’Université de Montréal.
S’inscrire à un programme de doctorat (Ph.D.) dans le domaine de la dermatologie dans un établissement reconnu.

Domaine d'études visé

Étudiant en médecine
Résident en dermatologie

Autres informations

Pour toute question ou information supplémentaire, veuillez contacter : [email protected]

Date limite de soumission

Les demandes de bourse doivent être soumises d’ici le 1er décembre 2026.

Childhood Eczema Challenge Grant – PeDRA

Date limite : 5:00PM PT, Friday, August 14, 2026

Pour en savoir plus

Montant

Up to $50,000 to support one year of research

Objectifs

This Challenge Grant is intended to stimulate early and mid-career scientists as they seek to build and sustain careers as research investigators and future thought leaders within this critical field of study.

Description de la bourse

Research proposals should address at least one of the following priorities related to pediatric eczema:

Eczema Heterogeneity: Novel Insights
Projects aimed at advancing understanding of the underlying factors contributing to the diversity of pediatric eczema clinical presentation, treatment response and comorbidities.
Innovations in Clinical Practice & Care
Studies addressing approaches to facilitate optimal identification and treatment of pediatric eczema and associated comorbidities in all health care settings to enhance patient/caregiver-reported and patient/caregiver-centric outcomes.
Understanding & Alleviating Disease Burden
Insightful proposals that identify, quantify, or aim to reduce aspects of pediatric eczema burden that negatively affect patient or family/caregiver quality of life (including lifestyle, academic, occupational, or economic impacts) based on patient population, treatment approach, etc.
Eczema Prevention
Novel investigations into the potential risk factors and strategies of primary eczema prevention in the pediatric population.

Priority will be given to proposals that focus on clinical or translational research, are broadly applicable, and include a patient-centered or comparative effectiveness framework. Applications that support NEA’s and PeDRA’s commitment to advancing equity, diversity, and inclusion across all facets of their organizations and research are encouraged. Proposals that include basic research will be accepted, however, they should be combined with a significant clinical or translational component. Proposals related to the development or enhancement of mobile apps will not be accepted.

Critères d'admissibilité

Early and mid‐career investigators (Associate Professor level or below and within 15 years of finishing training) are eligible to apply. Applicants need not be trained in pediatric dermatology but must hold the degree of MD and/or PhD (or equivalent) and be eligible to apply for grants under the guidelines of their host institution. Applications may be submitted by either a single investigator or multiple investigators at multiple institutions. Applicants need not be United States citizens and the research need not be conducted in the United States. Applicants may not hold current R‐level
2026 Childhood Eczema Challenge Grant RFP funding from NIH (or (or equivalent) as PI or Co‐PI, however, recipients of past or current NEA and/or PeDRA grants are eligible to apply.

Domaine d'études visé

Autres informations

Follow the instructions at https://nationaleczema.org/grant‐application/ to download the application packet and submit complete applications.

Awards made: By February 2, 2027
Earliest start date: March 1, 2027

Email [email protected] or [email protected] for additional information or with any questions on the Challenge Grant, application, or review process.

Date limite de soumission

5:00PM PT, Friday, August 14, 2026

Pediatric Hidradenitis Suppurativa Challenge

Date limite : Thursday, July 30, 2026

Pour en savoir plus

Montant

Up to $50,000 to support one year of research

Objectifs

Hidradenitis suppurativa (HS) is a devastating chronic inflammatory disease that manifests as recurrent painful nodules under the skin in the intertriginous areas of the body. It is associated with significant impacts on quality of life, psychosocial well-being, and long-term health outcomes of patients as well as consequences for families and caregivers. HS is prevalent, affecting between 1 and 4% of the population beginning in adolescence and persisting into adulthood. Despite the impact of HS, it remains underdiagnosed, undertreated, and understudied particularly in the pediatric and adolescent populations. Contributing to this dynamic are unknowns related to a complex disease etiology, stigma associated with HS symptoms (e.g., sweating, itching, and scarring commonly in the genital region), and limited treatment options to date with even fewer available for children under the age of 12.

To address the needs of children and adolescents living with HS, the Pediatric Dermatology Research Alliance (PeDRA), HS Connect, and the HS Foundation are offering the 2026 Pediatric HS Challenge Grant to support an early-to-mid career investigator for a one-year project focused on a high-priority, patient-centric research topic.

Description de la bourse

Proposals should address one or more of the following high-priority research topics:

Predicting treatment effectiveness and risk utilizing real world evidence and/or experience
Early disease and factors involved in severe disease development
Optimizing surgical and procedural approaches to minimize pain, shorten healing time, and reduce recurrence
Improving recruitment of diverse and representative populations for clinical studies, trials and advanced therapeutics

Critères d'admissibilité

Proposals may be submitted by a single principal investigator or team of investigators, as they seek to build and sustain a larger scale research program within this critical field of study. Projects may be conducted in the areas of basic science, translational research, clinical research, epidemiology, or technology. Priority consideration will be given to projects led by early-to-mid career principal investigators who are part of multidisciplinary teams including researchers, clinicians, and patient stakeholders. Additional priority will be given to applications that support PeDRA, HS Connect, and HS Foundation’s shared commitments to advancing equity, diversity, and inclusion and those that demonstrate a plan to leverage outcomes to form the basis for larger scale future projects.